Computational pathology-informed immune biomarker for trastuzumab benefit in HER2+ breast cancer: Validation in NSABP B-41 clinical trial. Analysis of event-free survival (EFS) of stromal tumor ...
The FDA removed safety warnings from several hormone drugs used to treat menopause symptoms. Here’s what you need to know about these treatments before your next doctor's appointment.
Barcelona researchers at the Hospital Clínic-IDIBAPS Research Institute, the University of Barcelona and the SOLTI academic cancer research group have shown that the molecular classification of breast ...
Hormones help certain types of breast, prostate, and some other cancers to grow. If you have one of them, your doctor may recommend hormone therapy to slow the cancer's growth or stop it from ...
At long last, the Food and Drug Administration will remove a “black box warning” label required on the packaging of most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback